Results: 45 Articles found.
  • Healthcare Distribution Alliance Names Chip Davis President and Chief Executive Officer
    February 10, 2020

    The Healthcare Distribution Alliance (HDA) Board of Directors’ Executive Committee today announced the appointment of Chester “Chip” Davis, Jr., JD, to the position of President and Chief Executive Officer. Mr. Davis will join HDA during March of this year. Chip joins HDA coming from the Association for Accessible Medicines (AAM), the nation’s leading trade association for manufacturers of generic and biosimilar medicines, where he has served as President and Chief Executive Officer since 2015.

  • HDA Responds to GAO Report on Suspicious Orders
    February 3, 2020

    HDA Executive Vice President of Government Affairs Patrick Kelly released the following statement in response to a new Government Accountability Office (GAO) report, Drug Control: Actions Needed to Ensure Usefulness of Data on Suspicious Opioid Orders.

  • HDA Research Foundation Selects Supply Chain Scholars
    January 30, 2020

    The HDA Research Foundation honored three graduate students as the recipients of its second annual scholarship.

  • HDA Statement on Proposed HHS Rule on Prescription Drug Importation
    December 18, 2019

    The Healthcare Distribution Alliance (HDA) released the following statement regarding the Department of Health and Human Services' (HHS) proposed rule permitting prescription drug importation.

  • HDA Statement on Senate Judiciary Committee Hearing on Mitigating the Opioid Crisis
    December 17, 2019

    The Healthcare Distribution Alliance (HDA) released the following statement following the organization’s testimony before the Senate Judiciary Committee on “Tackling the Opioid Crisis: A Whole-of-Government Approach.”

© 2020 Healthcare Distribution Alliance. All rights reserved.